Radiotherapy Market by Product (Devices [LINAC, Gamma Knife, Cyber Knife, Cyclotron, Synchrotron, Brachytherapy], Services, Software) Technology (IMRT, IGRT, 3D-CRT, Proton Beam Therapy, PDR-BT) Cancer (Breast, Prostate, Lung)

Description

List of Tables

Radiotherapy Market Size, Share, Forecast, & Trends Analysis by Product (Devices [LINAC, Gamma Knife, Cyber Knife, Synchrotron, Brachytherapy], Services, Software) Technology (IMRT, 3D-CRT, PDR-BT) Cancer (Breast, Prostate, Lung)-Global Forecast to 2030

The global radiotherapy market is projected to reach $17.86 billion by 2030 at a CAGR of 8.4% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The market drivers are the increasing cancer incidence rate, technological advancements radiotherapy, growing awareness about the benefits of radiotherapy for cancer treatment, growing healthcare expenditure, and growing use of particle therapy for cancer treatment. The market growth is hindered by the high costs and complexities of radiotherapy procedures, inadequate advanced infrastructure, and a shortage of skilled healthcare professionals.

Furthermore, the high growth prospects in emerging economies and rising investments by public & private organizations in cancer research are expected to offer significant market growth opportunities. However, the difficulties in visualizing tumors during radiotherapy procedures and the risks associated with radiation exposure are the major challenges to the market's growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2023). The key players operating in the global radiotherapy market are Siemens Healthineers AG (Germany), Elekta AB (Sweden), Accuray Incorporated (U.S.), IBA (Belgium), Mevion Medical Systems, Inc. (U.S.), Hitachi, Ltd. (Japan), ViewRay Technologies, Inc. (U.S.), Panacea Medical Technologies Pvt. Ltd. (India), IsoRay, Inc. (U.S.), Optivus Proton Therapy, Inc. (U.S.), and P-Cure Ltd. (Israel).

Among all the products studied in this report, in 2023, the radiotherapy devices segment is expected to account for the largest share of the radiotherapy market. The two types of radiotherapy devices are external and internal beam radiotherapy devices. CyberKnife is a form of non-invasive therapy that uses high doses of specifically designed radiation to eliminate cancers in the body. The adoption of CyberKnife is significantly higher than other external beam devices. The large market share of this segment is attributed to the benefits of CyberKnife, for its painless, non-invasive nature with few to no side effects.

Among all the technologies studied in this report, in 2023, the external beam radiotherapy segment is expected to account for the largest share of the radiotherapy market. The large market share of this segment is attributed to the high precision of external beam therapy. The developments in external beam therapy allow for higher and more precise radiation doses and reduce damage to healthy tissues. Moreover, the preference for external radiotherapy is higher among patients unsuitable for surgery.

Among all the cancer types studied in this report, in 2023, the prostate cancer segment is expected to account for the largest share of the radiotherapy market. The largest share of this segment is attributed to the high incidence of prostate cancer, and higher success rate of radiotherapy in prostate cancer than other cancers. For instance, according to Radiation Oncology Targeting Cancer data, external-beam radiation therapy cures 95.5% of men with localized prostate cancer.

An in-depth analysis of the geographical scenario of the global radiotherapy market provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa), along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the radiotherapy market. In 2023, the U.S. is expected to account for the largest share of the radiotherapy market in North America. The large share of this regional market is attributed to the high healthcare expenditure for cancer, highly developed healthcare infrastructure, the presence of key cancer radiotherapy developing companies such as Accuray Incorporated (U.S.) and Mevion Medical Systems, Inc. (U.S.), and government programs supporting early cancer screening.

Scope of the Report:

Radiotherapy Market Assessment-by Product

Radiotherapy Devices
- External-beam Radiotherapy
Conventional Linear Accelerators
Conventional Co-60 Teletherapy Units
Advanced Stereotactic Radiotherapy Systems
Gamma Knife
CyberKnife
TomoTherapy
- Proton Beam Therapy Systems/Particle Beam Therapy Systems
Cyclotron
Synchrotron
Synchrocyclotron
- Internal Beam Radiotherapy Systems/Brachytherapy Systems Seeds
Electronic Brachytherapy Products Applicators
Afterloaders
- Radiotherapy Consumables and Accessories
- Services
- Software

Radiotherapy Market Assessment-by Technology

External Beam Radiotherapy
- Intensity Modulated Radiation Therapy (IMRT)
- Image Guided Radiation Therapy (IGRT)
- Stereotactic Radiation Therapy (SRT)
- 3D Conformal Radiation Therapy (3D-CRT)
- Proton Beam Therapy/Particle Beam Therapy
Internal Beam Radiotherapy
- Brachytherapy
High dose-rate Brachytherapy
Low dose-rate Brachytherapy
Image Guided Brachytherapy
Pulse dose-rate Brachytherapy
- Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy

Radiotherapy Market Assessment-by Cancer Type

Breast Cancer
Prostate Cancer
Lung Cancer
Head and Neck Cancer
Colorectal Cancer
Cervical Cancer
Other Cancers

Note: Other cancers include kidney cancer, ovarian cancer, pancreatic cancer, and stomach cancer.

Radiotherapy Market Assessment-by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa

Product Code: MRHC - 104323

1. Overview

1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process of Data Collection and Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Drivers
- 4.2.1. Rising Cancer Incidence
- 4.2.2. Technological Advancements in the Field of Radiotherapy
- 4.2.3. Growing Awareness About the Benefits of Radiotherapy for Cancer Treatment
- 4.2.4. Growing Healthcare Expenditure
- 4.2.5. Rising Use of Particle Therapy for Cancer Treatment
4.3. Restraints
- 4.3.1. High Cost and Complexities Associated with Radiotherapy Procedures
- 4.3.2. Lack of Advanced Infrastructure Facilities
- 4.3.3. Lack of Skilled Healthcare Professionals
4.4. Opportunities
- 4.4.1. High Growth Prospects in Emerging Economies
- 4.4.2. Rising Investments by Public and Private Organizations for Cancer Research
4.5. Challenges
- 4.5.1. Difficulties in Visualizing Tumors during Radiotherapy Procedures
- 4.5.2. Risks Associated with Radiation Exposures
4.6. Pricing Analysis

5. Global Radiotherapy Market Size & Trend Analysis, by Product

5.1. Overview
5.2. Radiotherapy Devices
- 5.2.1. External Beam Radiotherapy
  - 5.2.1.1. Conventional Linear Accelerators
  - 5.2.1.2. Conventional Co-60 Teletherapy Units
  - 5.2.1.3. Advanced Stereotactic Radiotherapy Systems
    - 5.2.1.3.1. Gamma Knife
    - 5.2.1.3.2. CyberKnife
    - 5.2.1.3.3. TomoTherapy
  - 5.2.1.4 Proton Beam Therapy Systems/Particle Beam Therapy Systems
    - 5.2.1.4.1. Cyclotron
    - 5.2.1.4.2. Synchrotron
    - 5.2.1.4.3. Synchrocyclotron
- 5.2.2. Internal Beam Radiotherapy Systems/Brachytherapy Systems
  - 5.2.2.1. Electronic Brachytherapy Products
  - 5.2.2.2. Afterloaders
5.3. Radiotherapy Consumables and Accessories
5.4. Services
5.5. Software

6. Global Radiotherapy Market Size & Trend Analysis, by Technology

6.1. Overview
6.2. External Beam Radiotherapy
- 6.2.1. Intensity-Modulated Radiation Therapy (IMRT)
- 6.2.2. Image-Guided Radiation Therapy (IGRT)
- 6.2.3. Stereotactic Radiation Therapy (SRT)
- 6.2.4. 3D Conformal Radiation Therapy (3D-CRT)
- 6.2.5. Proton Beam Therapy/ Particle Beam Therapy
6.3. Internal Beam Radiotherapy
- 6.3.1. Brachytherapy
  - 6.3.1.1. High Dose Rate Brachytherapy
  - 6.3.1.2. Low Dose Rate Brachytherapy
  - 6.3.1.3. Image Guided Brachytherapy
  - 6.3.1.4. Pulse Dose Rate Brachytherapy
- 6.3.2. Systemic Radiation Therapy
  - 6.3.2.1. Intravenous Radiotherapy
  - 6.3.2.2 Oral Radiotherapy

7. Global Radiotherapy Market Size & Trend Analysis, by Cancer Type

7.1. Overview
7.2. Breast Cancer
7.3. Prostate Cancer
7.4. Lung Cancer
7.5. Head and Neck Cancer
7.6. Colorectal Cancer
7.7. Cervical Cancer
7.8. Other Cancers

8. Radiotherapy Market Size & Trend Analysis, by Geography

8.1. Overview
8.2. North America
- 8.2.1. U. S.
- 8.2.2. Canada
8.3. Europe
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Rest of Europe
8.4. Asia-Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. Rest of Asia-Pacific
8.5. Latin America
- 8.5.1. Brazil
- 8.5.2. Mexico
- 8.5.3. Rest of Latin America
8.6. Middle East & Africa

9. Competition Analysis

9.1. Overview
9.2. Key Growth Strategies
9.3. Vendor Market Positioning
9.4. Competitive Dashboard
- 9.4.1. Industry Leaders
- 9.4.2. Market Differentiators
- 9.4.3. Vanguards
- 9.4.4. Emerging Companies
9.5. Market Share Analysis (2022)

10. Company Overview (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

10.1. Siemens Healthineers AG
10.2. Elekta AB
10.3. Accuray Incorporated
10.4. IBA
10.5. Mevion Medical Systems, Inc.
10.6. Hitachi, Ltd.
10.7. ViewRay Technologies, Inc.
10.8. Panacea Medical Technologies Pvt. Ltd.
10.9. IsoRay, Inc.
10.10. Optivus Proton Therapy, Inc
10.11. P-Cure, Ltd.

11. Appendix

11.1. Available Customization
11.2. Related Reports